Neurocrine Biosciences (NBIX) Non-Current Deferred Revenue (2009 - 2018)
Neurocrine Biosciences (NBIX) recorded Non-Current Deferred Revenue of $10.23 million in Q4 2018, unchanged from $10.23 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Non-Current Deferred Revenue (2009 - 2018) Analysis & Trends
Starting with Q4 2010, Neurocrine Biosciences' Non-Current Deferred Revenue history includes 23 quarters.
- Annual Non-Current Deferred Revenue has a three-year compound annual growth rate of 0.0% (FY2015 to FY2018).
- Across earlier years, Non-Current Deferred Revenue came in at $10.23 million in FY2017 (unchanged), $10.23 million in FY2016 (unchanged) and $10.23 million in FY2015.
- Per Business Quant, the preceding three quarters came in at $10.23 million (Q3 2018), $10.23 million (Q2 2018) and $10.23 million (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 10.23 Mn |
| Sep 30, 2018 | 10.23 Mn |
| Jun 30, 2018 | 10.23 Mn |
| Mar 31, 2018 | 10.23 Mn |
| Dec 31, 2017 | 10.23 Mn |
| Sep 30, 2017 | 10.23 Mn |
| Jun 30, 2017 | 10.23 Mn |
| Mar 31, 2017 | 10.23 Mn |
| Dec 31, 2016 | 10.23 Mn |
| Sep 30, 2016 | 10.23 Mn |
| Jun 30, 2016 | 10.23 Mn |
| Mar 31, 2016 | 10.23 Mn |
| Dec 31, 2015 | 10.23 Mn |
| Sep 30, 2015 | 10.23 Mn |
| Jun 30, 2015 | 10.23 Mn |
| Mar 31, 2015 | 10.23 Mn |
| Dec 31, 2013 | 800,000.00 |
| Sep 30, 2012 | 728,000.00 |
| Jun 30, 2012 | 1.46 Mn |
| Mar 31, 2012 | 2.19 Mn |
API Access
Neurocrine Biosciences Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();